Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000735

Drug Information
NameNabumetone    
SynonymsBRL-14777; Relafen; NCGC00095063-02; HMS2090D13; SPECTRUM1503650; N6142_SIGMA; Consolan; Relif; Apotex Brand of Nabumetone; Mayoly-Spindler Brand of Nabumetone; Flambate; AC1Q4F4K; BIDD:GT0104; KBioGR_000687; CPD000058835; Rhoxal-nabumetone; nchembio.128-comp30; SmithKline Beecham Brand of Nabumetone; Nabumetone (JAN/USP/INN); CCRIS 8108; Prestwick3_000909; IDI1_000850; KBio2_001966; NCGC00095063-01; DivK1c_000850; HMS1922G10; BRL 14777; KBioSS_001966; MolPort-001-793-710; KBio2_007102; nabumetone; Nabucox; AC1L1I3P; SPBio_002097; Prodac; AC-19025; Prestwick0_000909; Prestwick2_000909; CAS-42924-53-8; Nabumetonum; BPBio1_000834; Gen-Nabumetone; Relifex; MLS000069541; NCGC00016853-01; Nabumetona; SAM002564225; AB00052392; Relifen; HMS1570F20; D00425; BRN 2103472; 42924-53-8; Apo-Nabumetone; Spectrum_001486; SMR000058835; Ambap42924-53-8; Arthraxan; BSPBio_000758; Uriach Brand of Nabumetone; 4-(6-Methoxy-2-naphthalenyl)-2-butanone; Nabumetonum [INN-Latin]; HMS2093I05; KBio2_004534; MLS001076325; KBio1_000850; CID4409; 4-(6-methoxynaphthalen-2-yl)butan-2-one; HMS502K12; Dolsinal; CHEMBL1070; C035605; LS-46825; Nabuser; UNII-LW0TIW155Z; Genpharm Brand of Nabumetone; Nabumetone [USAN:BAN:INN:JAN]; Mebutan; N6142_FLUKA; SmithKline Brand of Nabumetone; Arthaxan; Prestwick1_000909; Unimetone; nabumeton; Spectrum2_001969; Spectrum5_001286; DB00461; Spectrum4_000174; BRD-K65146499-001-04-8; Listran; Balmox; Wassermann Brand of Nabumetone; GlaxoSmithKline Brand of Nabumetone; 4-(6-Methoxy-2-naphthyl)-2-butanone; SPBio_002957; Relafen (TN); Rhoxalpharma Brand of Nabumetone; ZINC00020221; 2-Butanone, 4-(6-methoxy-2-naphthalenyl)-; NINDS_000850    
Trade NameRelafen; Relifex; Gambaran    
CompanyBeecham phamaceuticals    
IndicationRheumatoid arthritis and osteoarthritisApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnti-Inflammatory Agents    
CAS NumberCAS 42924-53-8
FormularC15H16O2    
PubChem Compound IDCID 4409.    
PubChem Substance IDSID 180363.    
SuperDrug ATC IDM01AX01;    
SuperDrug CAS ID042924538;    
TargetProstaglandin G/H synthase 2Inhibitor[2][3]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Novel determination of nabumetone, a cox-2 inhibitor precursor via its 4-carboxyl-2,6-dinitrobenzene diazonium (CDNBD) derived AZO dye. Afr J Med Med Sci. 2007 Sep;36(3):249-57. To Reference
Ref 3Cyclo-oxygenase 2 inhibitor, nabumetone, inhibits proliferation in chronic myeloid leukemia cell lines. Leuk Lymphoma. 2005 May;46(5):753-6. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543